Last Updated: September 24, 2026

Patent: 10,034,927

✉ Email this page to a colleague

Summary for Patent: 10,034,927

Title:	Methods and compositions relating to synthetic beta-1,6 glucosamine oligosaccharides
Abstract:	The invention relates to the compositions of synthetic oligo-β-(1→6)-2-amino-2-deoxy-D-glu-copyranosides conjugated to carriers, and methods for making and use same.
Inventor(s):	Gerald B. Pier, Nikolay Nifantiev, Yury Tsvetkov, Marina Gening
Assignee:	Brigham and Womens Hospital Inc
Application Number:	US15/258,417
Patent Claims:	see list of patent claims

Details for Patent 10,034,927

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Alexion Pharmaceuticals, Inc.	STRENSIQ	asfotase alfa	Injection	125513	23-Oct-15	10,034,927	2036-09-07
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 10,034,927

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
Australia	2009274630	⤷ Start Trial
Brazil	PI0916365	⤷ Start Trial
Canada	2731384	⤷ Start Trial
China	102159540	⤷ Start Trial
China	105085349	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.